«MOZEC SEB»
The MOZEC™ SEB is an innovative sirolimus-eluting coronary balloon, designed for precise vessel dilation and effective local drug delivery without metal. It ensures controlled and targeted release of sirolimus through a unique Solid Lipid Nano Spheres (SLN) nanotechnology, providing treatment for in-stent restenosis and complex vascular lesions without additional metal load.
Advantages
- Unique Solid Lipid Nano Spheres (SLN) composition with sirolimus + lipids for targeted drug delivery.
- 3.00 μg/mm² sirolimus equivalent dose (twice that of other DCBs) for optimal therapeutic effect.
- Polymer-free, with no filler material left behind in the vessel.
- Different nanoparticle sizes allow drug delivery to every layer of the vessel wall.
- Rapid drug release into the tissue during dilation.
Use
The MOZEC SEB is indicated for PTCA angioplasty in coronary vessels with:
In-Stent Restenosis (ISR): Treatment of restenosis within a stent without additional metal load.
Small Vessels: Vessels with a diameter of 2.0–2.5 mm with a high risk of re-narrowing.
Bifurcation Lesions: Bifurcation lesions requiring side branch protection.
De-Novo Lesions: Primary lesions in patients at high risk for stent thrombosis.
Available sizes:
Balloon diameter: 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00, 4.50 mm
Balloon length: 9, 12, 14, 15, 17, 20, 25, 30 mm
Catheter system: Rapid Exchange (Rx)
Usable length: 142 cm
Guide catheter compatibility: 5 F (minimum I.D. 0.056″ / 1.42 mm)
Guidewire compatibility: 0.014″ (0.36 mm)
The innovative Nanotech Novel Drug Delivery technology ensures 100% coverage of the balloon surface with uniform drug distribution, without any polymer remaining on the vessel wall.
